Business
Immune Therapeutics, Inc. Announces Exclusive Agreement For Sale Of Lodonal In Kenya Valued At Over $31 Million
Immune Therapeutics, Inc. Announces Exclusive Agreement For Sale Of Lodonal In Kenya Valued At Over $31 Million.
About this update from Biostax Corp.
[{"type":"text","content":"\n\n\n\nImmune Therapeutics, Inc. Announces Exclusive Agreement For Sale Of Lodonal In Kenya Valued At Over $31 Million\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nImmune Therapeutics, Inc. Announces Exclusive Agreement For Sale Of Lodonal In Kenya Valued At Over $31 Million\nAgreement Illustrates Immune Therapeutics' Commitment to Providing an Effective and Affordable Non-Toxic Treatment for HIV/AIDS Patients\nPR Newswire\nORLANDO, Fla., Sept. 6, 2017\n\n\n\nORLANDO, Fla., Sept. 6, 2017 /PRNewswire/ -- Immune Therapeutics, Inc. (OTCQB: IMUN), a specialty pharmaceutical company focused on developing and commercializing Lodonal™, its patented, affordable, non-toxic therapy for the management of cancer, HIV, autoimmune diseases and other inflammatory conditions, today announced that it has entered into an exclusive agreement with Kenya-based Omaera Pharmaceuticals, Ltd. for the sale and distribution of Lodonal™, valued at a minimum of $31 million in revenues over three years.  \n\nUnder the terms of the agreement:\n\n\nOmaera will supply Lodonal to patients exclusively in Kenya, where 5.9% of the country's 47 million population live with HIV/AIDS.\nImmune Therapeutics will sell Lodonal to Omaera at a rate of $0.65 per pill, or $19.50 per carton\nIt requires a minimum purchase commitment of over one million pills in the first six months; over 3.6 million pills in the second half of the first year; and 14.4 million and 28.8 million in the second and third years, respectively.\nOmaera Territory includes six countries: Republic of Kenya, Republic of Uganda United Republic of Tanzania, Republic of Burundi and Republic of Rwanda. Making up the East Africa Community.\nBased on numbers from Avert there are 4,670,000 living with HIV in the region\nOmaera was launched in 1993 as a locally owned wholesaling operation that has grown into one of the most recognized medical supply and distribution companies in East Africa. \nDr. J. Njoroge, Managing Director of Omaera Pharmaceuticals, Ltd., said \"Following the finalization of the distribution agreement with Im...